135 related articles for article (PubMed ID: 20939760)
21. Association of Merkel cell polyomavirus infection with EGFR mutation status in Chinese non-small cell lung cancer patients.
Xu S; Jiang J; Yu X; Sheng D; Zhu T; Jin M
Lung Cancer; 2014 Mar; 83(3):341-6. PubMed ID: 24485957
[TBL] [Abstract][Full Text] [Related]
22. Concordance between epidermal growth factor receptor status in primary non-small-cell lung cancer and metastases: a post-mortem study.
Watzka SB; Rauscher-Pötsch I; Nierlich P; Setinek U; Köstler WJ; Pötschger U; Müller MR; Attems J
Eur J Cardiothorac Surg; 2010 Jul; 38(1):34-7. PubMed ID: 20353893
[TBL] [Abstract][Full Text] [Related]
23. Immunohistochemical analysis of phosphorylated epidermal growth factor receptor might provide a surrogate marker of EGFR mutation.
Endoh H; Ishibashi Y; Yamaki E; Yoshida T; Yajima T; Kimura H; Kosaka T; Onozato R; Tanaka S; Mitsudomi T; Kuwano H
Lung Cancer; 2009 Feb; 63(2):241-6. PubMed ID: 18585821
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical screening for anaplastic lymphoma kinase (ALK) rearrangement in advanced non-small cell lung cancer patients.
Park HS; Lee JK; Kim DW; Kulig K; Kim TM; Lee SH; Jeon YK; Chung DH; Heo DS
Lung Cancer; 2012 Aug; 77(2):288-92. PubMed ID: 22465695
[TBL] [Abstract][Full Text] [Related]
25. Epidermal growth factor receptor mutations: effect on volume doubling time of non-small-cell lung cancer patients.
Nakamura R; Inage Y; Tobita R; Mori K; Numata T; Yanai H; Endo T; Ohtani H; Satoh H; Yuzawa K; Koizumi M; Ueki H
J Thorac Oncol; 2014 Sep; 9(9):1340-4. PubMed ID: 24481317
[TBL] [Abstract][Full Text] [Related]
26. EGFR mutant-specific immunohistochemistry has high specificity and sensitivity for detecting targeted activating EGFR mutations in lung adenocarcinoma.
Cooper WA; Yu B; Yip PY; Ng CC; Lum T; Farzin M; Trent RJ; Mercorella B; Clarkson A; Kohonen-Corish MR; Horvath LG; Kench JG; McCaughan B; Gill AJ; O'Toole SA
J Clin Pathol; 2013 Sep; 66(9):744-8. PubMed ID: 23757037
[TBL] [Abstract][Full Text] [Related]
27. Mutation-specific antibodies for the detection of EGFR mutations in non-small-cell lung cancer.
Yu J; Kane S; Wu J; Benedettini E; Li D; Reeves C; Innocenti G; Wetzel R; Crosby K; Becker A; Ferrante M; Cheung WC; Hong X; Chirieac LR; Sholl LM; Haack H; Smith BL; Polakiewicz RD; Tan Y; Gu TL; Loda M; Zhou X; Comb MJ
Clin Cancer Res; 2009 May; 15(9):3023-8. PubMed ID: 19366827
[TBL] [Abstract][Full Text] [Related]
28. Cyclooxygenase-2 protein levels are independent of epidermal growth factor receptor expression or activation in operable non-small cell lung cancer.
Richardson CM; Richardson D; Swinson DE; Swain WA; Cox G; O'Byrne KJ
Lung Cancer; 2005 Apr; 48(1):47-57. PubMed ID: 15777970
[TBL] [Abstract][Full Text] [Related]
29. Negative NKX2-1 (TTF-1) as temporary surrogate marker for treatment selection during EGFR-mutation analysis in patients with non-small-cell lung cancer.
Vincenten J; Smit EF; Vos W; Grünberg K; Postmus PE; Heideman DA; Snijders PJ; Meijer G; Kuik J; Witte BI; Thunnissen E
J Thorac Oncol; 2012 Oct; 7(10):1522-7. PubMed ID: 22982653
[TBL] [Abstract][Full Text] [Related]
30. Use of mutation specific antibodies to detect EGFR status in small biopsy and cytology specimens of lung adenocarcinoma.
Hasanovic A; Ang D; Moreira AL; Zakowski MF
Lung Cancer; 2012 Aug; 77(2):299-305. PubMed ID: 22542171
[TBL] [Abstract][Full Text] [Related]
31. What's new in non-small cell lung cancer for pathologists: the importance of accurate subtyping, EGFR mutations and ALK rearrangements.
Cooper WA; O'toole S; Boyer M; Horvath L; Mahar A
Pathology; 2011 Feb; 43(2):103-15. PubMed ID: 21233671
[TBL] [Abstract][Full Text] [Related]
32. The peptide nucleic acid-locked nucleic acid polymerase chain reaction clamp-based test for epidermal growth factor receptor mutations in bronchoscopic cytological specimens of non-small cell lung cancer.
Yamada N; Oizumi S; Asahina H; Shinagawa N; Kikuchi E; Kikuchi J; Sakakibara-Konishi J; Tanaka T; Kobayashi K; Hagiwara K; Nishimura M
Oncology; 2012; 82(6):341-6. PubMed ID: 22677909
[TBL] [Abstract][Full Text] [Related]
33. An Analysis of EGFR Mutations among 1506 Cases of Non-Small Cell Lung Cancer Patients in Guangxi, China.
Wei WE; Mao NQ; Ning SF; Li JL; Liu HZ; Xie T; Zhong JH; Feng Y; Wei CH; Zhang LT
PLoS One; 2016; 11(12):e0168795. PubMed ID: 27992557
[TBL] [Abstract][Full Text] [Related]
34. Association of epidermal growth factor receptor mutations with human papillomavirus 16/18 E6 oncoprotein expression in non-small cell lung cancer.
Tung MC; Wu HH; Cheng YW; Wang L; Chen CY; Yeh SD; Wu TC; Lee H
Cancer; 2013 Sep; 119(18):3367-76. PubMed ID: 23797467
[TBL] [Abstract][Full Text] [Related]
35. Impact of family history of cancer on the incidence of mutation in epidermal growth factor receptor gene in non-small cell lung cancer patients.
He Y; Li S; Ren S; Cai W; Li X; Zhao C; Li J; Chen X; Gao G; Li W; Zhou F; Zhou C
Lung Cancer; 2013 Aug; 81(2):162-6. PubMed ID: 23726438
[TBL] [Abstract][Full Text] [Related]
36. Immunohistochemical detection of mutated epidermal growth factor receptors in pulmonary adenocarcinoma.
Nakamura H; Mochizuki A; Shinmyo T; Ando K; Kurimoto N; Yokote K; Takagi M
Anticancer Res; 2010 Dec; 30(12):5233-7. PubMed ID: 21187519
[TBL] [Abstract][Full Text] [Related]
37. Analytical performance of the cobas EGFR mutation assay for Japanese non-small-cell lung cancer.
Kimura H; Ohira T; Uchida O; Matsubayashi J; Shimizu S; Nagao T; Ikeda N; Nishio K
Lung Cancer; 2014 Mar; 83(3):329-33. PubMed ID: 24439568
[TBL] [Abstract][Full Text] [Related]
38. Lack of direct association between EGFR mutations and ER beta expression in lung cancer.
Onitsuka T; Uramoto H; Tanaka F
Anticancer Res; 2011 Mar; 31(3):855-60. PubMed ID: 21498706
[TBL] [Abstract][Full Text] [Related]
39. RET finger protein expression is associated with prognosis in lung cancer with epidermal growth factor receptor mutations.
Iwakoshi A; Murakumo Y; Kato T; Kitamura A; Mii S; Saito S; Yatabe Y; Takahashi M
Pathol Int; 2012 May; 62(5):324-30. PubMed ID: 22524660
[TBL] [Abstract][Full Text] [Related]
40. Reproducibility of immunohistochemical scoring for epidermal growth factor receptor expression in non-small cell lung cancer: round robin test.
Rüschoff J; Kerr KM; Grote HJ; Middel P; von Heydebreck A; Alves VA; Baldus SE; Büttner R; Carvalho L; Fink L; Jochum W; Lo AW; López-Ríos F; Marx A; Molina TJ; Olszewski WT; Rieker RJ; Volante M; Thunnissen E; Wrba F; Celik I; Störkel S
Arch Pathol Lab Med; 2013 Sep; 137(9):1255-61. PubMed ID: 23270410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
